Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 0.76% is 14% below its 5-year average of 0.88%, around the middle of its 5-year range (-2.80%–5.48%).
154.68% above its 12-month average of -1.39%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.48%.
RETURN ON ASSETS (ROA)
0.76%
RETURN ON ASSETS (ROA) AVG TTM
-1.39%
RETURN ON ASSETS (ROA) AVG 3Y
-1.28%
RETURN ON ASSETS (ROA) AVG 5Y
0.88%
RETURN ON ASSETS (ROA) AVG 10Y
3.07%
RETURN ON ASSETS (ROA) AVG 15Y
4.91%
RETURN ON ASSETS (ROA) AVG 20Y
6.42%
CURRENT VS TTM AVG
+154.68%
CURRENT VS 3Y AVG
+159.49%
CURRENT VS 5Y AVG
-13.96%
CURRENT VS 10Y AVG
-75.27%
CURRENT VS 15Y AVG
-84.53%
CURRENT VS 20Y AVG
-88.17%
SECTOR MEDIAN · HEALTHCARE
-28.05%
median of 558 covered companies
CURRENT VS SECTOR MEDIAN
+102.71%
vs the sector median at left
ICU Medical, Inc.
Market Cap
$3.98B
Return on Assets (ROA)
0.76%
TTM Avg
-1.39%
3Y Avg
-1.28%
5Y Avg
0.88%
Market Cap
$4.17B
Return on Assets (ROA)
7.14%
TTM Avg
-3.40%
3Y Avg
-2.46%
5Y Avg
-5.09%
Market Cap
$4.21B
Return on Assets (ROA)
-12.59%
TTM Avg
-11.38%
3Y Avg
-5.58%
5Y Avg
0.19%
Market Cap
$4.33B
Return on Assets (ROA)
-41.11%
TTM Avg
-28.92%
3Y Avg
-26.43%
5Y Avg
-22.29%
Market Cap
$3.62B
Return on Assets (ROA)
-1.28%
TTM Avg
-8.27%
3Y Avg
-17.73%
5Y Avg
-16.90%
Market Cap
$3.58B
Return on Assets (ROA)
20.83%
TTM Avg
2.76%
3Y Avg
-12.34%
5Y Avg
-9.97%
Market Cap
$3.53B
Return on Assets (ROA)
-13.36%
TTM Avg
-17.34%
3Y Avg
-16.80%
5Y Avg
-15.30%
Market Cap
$4.44B
Return on Assets (ROA)
28.79%
TTM Avg
8.79%
3Y Avg
1.95%
5Y Avg
1.56%
Market Cap
$3.49B
Return on Assets (ROA)
-27.35%
TTM Avg
-41.78%
3Y Avg
-34.97%
5Y Avg
-41.24%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ICU Medical, Inc. (ICUI) | $3.98B | 0.76% | -1.39% | -1.28% | 0.88% |
| LivaNova PLC (LIVN)vs › | $4.17B | 7.14% | -3.40% | -2.46% | -5.09% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.21B | -12.59% | -11.38% | -5.58% | 0.19% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.33B | -41.11% | -28.92% | -26.43% | -22.29% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.62B | -1.28% | -8.27% | -17.73% | -16.90% |
| CareDx, Inc (CDNA)vs › | $3.58B | 20.83% | 2.76% | -12.34% | -9.97% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.53B | -13.36% | -17.34% | -16.80% | -15.30% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.44B | 28.79% | 8.79% | 1.95% | 1.56% |
| Celcuity Inc. (CELC)vs › | $3.49B | -27.35% | -41.78% | -34.97% | -41.24% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.43B | -34.36% | -56.86% | -55.14% | -55.14% |
ROA
0.8%
ROE
1.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 0.02% |
| 2024-12-31 | -2.80% |
| 2023-12-31 | -0.68% |
| 2022-12-31 | -1.65% |
| 2021-12-31 | 5.48% |
| 2020-12-31 | 4.93% |
| 2019-12-31 | 5.97% |
| 2018-12-31 | 1.82% |
| 2017-12-31 | 4.59% |
| 2016-12-31 | 8.95% |
| 2015-12-31 | 7.18% |
| 2014-12-31 | 4.87% |
| 2013-12-31 | 8.09% |
| 2012-12-31 | 9.63% |
| 2011-12-31 | 12.28% |
| 2010-12-31 | 9.91% |
| 2009-12-31 | 8.59% |
| 2008-12-31 | 8.57% |
| 2007-12-31 | 9.51% |
| 2006-12-31 | 10.51% |
| 2005-12-31 | 9.91% |
| 2004-12-31 | 3.03% |
| 2003-12-31 | 13.57% |
| 2002-12-31 | 12.53% |
| 2001-12-31 | 13.11% |
| 2000-12-31 | 12.69% |
| 1999-12-31 | 12.47% |
| 1998-12-31 | 11.54% |
| 1997-12-31 | 11.13% |
| 1996-12-31 | 9.48% |
